Nonpolymeric nanoassemblies for ocular administration of acyclovir: Pharmacokinetic evaluation in rabbits
Authors:
- Barbara StellaBarbara Stella
- Silvia ArpiccoSASilvia Arpicco
- Flavio RoccoFRFlavio Rocco
- Susi BurgalassiSBSusi Burgalassi
- Nadia NicosiaNNNadia Nicosia
- Silvia TampucciSilvia Tampucci
- Patrizia ChetoniPatrizia Chetoni
- Luigi CattelLCLuigi Cattel
- 1 January 2012
- journal article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 80 (1) , 39-45
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Feasibility of Lipid Nanoparticles for Ocular Delivery of Anti-Inflammatory DrugsCurrent Eye Research, 2010
- Ocular Drug DeliveryThe AAPS Journal, 2010
- Transcorneal Permeation of l- and d-Aspartate Ester Prodrugs of Acyclovir: Delineation of Passive Diffusion Versus Transporter InvolvementPharmaceutical Research, 2008
- Synthesis, metabolism and cellular permeability of enzymatically stable dipeptide prodrugs of acyclovirInternational Journal of Pharmaceutics, 2008
- Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: Evaluation of their utility in treating ocular HSV infectionsInternational Journal of Pharmaceutics, 2008
- Comparison of Liposome-Encapsulated Acyclovir with Acyclovir Ointment: Ocular Pharmacokinetics in RabbitsJournal of Ocular Pharmacology and Therapeutics, 2004
- Ocular Drug DeliveryClinical Pharmacokinetics, 1990
- A convenient synthesis of 9-(2-hydroxyethoxymethyl)guanine(acyclovir) and related compounds.Chemical and Pharmaceutical Bulletin, 1988
- ProdrugsDrugs, 1985
- Acyclovir A Review of its Pharmacodynamic Properties and Therapeutic EfficacyDrugs, 1983